Mentalizing Skills Deficits in Schizophrenia as a Clue for Drug Choice: Clozapine Versus Other Antipsychotics on Keeping Outpatients Stable
نویسندگان
چکیده
Rosó Duñó1, Klaus Langohr2,3, Diego Palao1 and Adolf Tobeña4 1Parc Taulí University Hospital, Autonomous University of Barcelona, 2Pharmacology Research Unit, Institut Municipal d’Investigació Mèdica, Barcelona 3Department of Statistics and Operations Research, Technical University of Catalonia, Barcelona 4Department of Psychiatry and Forensic Medicine, Institute of Neurosciences, Autonomous University of Barcelona, Spain
منابع مشابه
Low Dose Celecoxib Combined with Clozapine for Treatment of Schizophrenia: A Double Blind Randomized Clinical Trial
Introduction: Higher levels of pro-inflammatory cytokines in schizophrenia have suggested that dysfunctions of the immune system may play a role in this disabling condition. The current study was performed to discover if low dose celecoxib combined with clozapine may improve symptoms of schizophrenia or not. Methods:<span...
متن کاملMetabolic syndrome in schizophrenia - who is more to blame: FGA polypharmacy or clozapine monotherapy?
BACKGROUND To establish the prevalence of metabolic syndrome and its parameters in group of patients with schizophrenia in polypharmacy - receiving first generation antipsychotics versus clozapine alone treated group. SUBJECTS AND METHODS 48 outpatients with schizophrenia divided into two groups: the first group of 21 patients in polypharmacy with first generation antipsychotics, and the seco...
متن کاملOverweight and obesity in schizophrenic patients taking clozapine compared to the use of other antipsychotics Carmen Lúcia Leitão - Azevedo
Background: The use of antipsychotics has been crucial in the treatment of schizophrenic patients. However, clozapine, as well as most atypical antipsychotics, may lead to higher weight gain and metabolic changes.Objective: To compare the frequency of overweight and obesity between schizophrenic patients exposed to clozapine to the prevalence of patients exposed to other antipsychotics....
متن کاملThe risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial.
BACKGROUND Despite little evidence to support its use and practice guidelines discouraging the practice, antipsychotic polypharmacy is widely prevalent in schizophrenia. This randomized controlled trial studied the effects of switching patients stable on two antipsychotic medications to one antipsychotic medication. METHOD 104 adult outpatients with schizophrenia from 7 community mental healt...
متن کاملAre cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?
Prepulse inhibition of startle (PPI), a measure of sensorimotor gating used to identify antipsychotics, is reduced in schizophrenia patients and in rodents treated with dopamine agonists or glutamate antagonists. The National Institute of Mental Health (NIMH)-funded Measurement And Treatment Research to Improve Cognition in Schizophrenia (MATRICS) program has initiated a new era in the developm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012